Drawing based on the label description. No photo yet.
“20-mg brown tablet engraved with "APR" on one side and "20" on the other side”
APR 20 pill
Pill with imprint APR 20 is brown, diamond, 10 mm and has been identified as Apremilast 20 mg. It is used for psoriatic arthritis. It is supplied by Amgen, Inc.
Apremilast 20 mg
- Imprint
- APR 20
- Strength
- 20 mg
- Used for
- Psoriatic arthritis
- Color
- Brown
- Shape
- Diamond
- Size
- 10 mm
- Score
- No score line
- Form
- Tablet, film coated
- Manufacturer
- Amgen, Inc
- Drug class
- Phosphodiesterase 4 inhibitor
- NDC
- 55513-369, 55513-369-55, 55513-485, 55513-485-95, 55513-485-96, 55513-497, 55513-497-60, 55513-508, 55513-508-55, 55513-518, 55513-518-04, 55513-497-51, 55513-996, 55513-996-96, 55513-996-95, 55513-497-23, 55513-516, 55513-516-41, 55513-517, 55513-517-04, 55513-523, 55513-523-04, 55513-521, 55513-521-19, 55513-522, 55513-522-14
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Apremilast used for?
Apremilast is used for psoriatic arthritis.
- Medicine type
- Phosphodiesterase 4 inhibitor
Official uses from the US prescribing label
Psoriatic Arthritis
OTEZLA is indicated for the treatment of adult patients and pediatric patients 6 years of age and older and weighing at least 20 kg with active psoriatic arthritis.
OTEZLA XR is indicated for the treatment of adult patients and pediatric patients 6 years of age and older and weighing at least 50 kg with active psoriatic arthritis.
Plaque Psoriasis
OTEZLA/OTEZLA XR is indicated for the treatment of adult patients with plaque psoriasis who are candidates for phototherapy or systemic therapy.
OTEZLA is indicated for the treatment of pediatric patients 6 years of age and older and weighing at least 20 kg with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
OTEZLA XR is indicated for the treatment of pediatric patients 6 years of age and older and weighing at least 50 kg with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
Oral Ulcers Associated with Behçet's Disease
OTEZLA/OTEZLA XR is indicated for the treatment of adult patients with oral ulcers associated with Behçet's Disease.
From the FDA-approved label on DailyMed (published Sep 11, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- One side shows APR and the other side shows 20.
- It is brown, diamond, 10 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold under the brand name Otezla.
One of the pills in the Otezla pack.
Ingredients
Active: Apremilast
Inactive: Lactose Monohydrate, Microcrystalline Cellulose, Croscarmellose Sodium, Magnesium Stearate, Polyvinyl Alcohol, Unspecified, Titanium Dioxide, Polyethylene Glycol, Unspecified, Talc, Ferric Oxide Red, Ferric Oxide Yellow
Other Apremilast pills
- APR 10 Apremilast 10 mg Pink, diamond, 8 mm Used for psoriatic arthritis
- APR 30 Apremilast 30 mg White, diamond, 12 mm Used for psoriatic arthritis
- AP 30 Apremilast 30 mg Brown, oval Used for psoriatic arthritis
- 30 Apremilast 30 mg Pink, diamond Used for psoriatic arthritis
- APR 75 Apremilast 75 mg Pink, round, 12 mm Used for psoriatic arthritis
- No picture yet DIN 02434334 Apremilast 30 mg Otezla, Tablet, sold in Canada Used for psoriatic arthritis
- No picture yet DIN 02518910 Apremilast 30 mg GLN-Apremilast, Tablet, sold in Canada Used for psoriatic arthritis
- No picture yet DIN 02521733 Apremilast 30 mg PMS-Apremilast, Tablet, sold in Canada Used for psoriatic arthritis